FDA clears 1st treatment for pancreatic cancer in 30 years, approving Optune Pax to improve survival with chemotherapy.
Zacks Investment Research on MSN
Novocure gains FDA approval for Optune Pax to treat pancreatic cancer
Novocure NVCR recently announced the FDA approval for its portable therapeutic device, Optune Pax, for treating adult ...
Researchers discovered that a long-misunderstood protein plays a key role in helping chromosomes latch onto the right “tracks” during cell division. Instead of acting like a motor, it works more like ...
Human disease including cancer arises from disfunction of essential processes within a cell. One essential cellular process is the copying of the genomic DNA—the road map of cells—followed by ...
Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...
Kateřina Jeřábková-Roda is involved in cancer research that links microscopic cellular changes to the hope of earlier ...
It's long been assumed that when a parent cell divides into two daughter cells, the parent assumes a spherical shape, which then splits into two cells that have roughly the same, round size. But a new ...
New findings reveal that succinate signaling through SUCNR1 acts as a protective brake in acute myeloid leukemia. Modulating this pathway influenced disease progression in mice and may guide future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results